Table 2. Relationship between DICER1 protein expression and baseline clinical or pathological characteristics of 79 adult patients with ACC (only tumor samples derived from primary surgery).
Weak DICER1 expression | Strong DICER1 expression | p | |
---|---|---|---|
n (%) | 40 (51%) | 39 (49%) | |
Score, median | 2.4 (0–3.5) | 5.4 (3.6–7.0) | |
Age, median (yr) | 35 (15–67) | 45 (18–81) | 0.02 |
Sex [male, n (%)] | 11 (28) | 6 (15) | 0.19 |
Tumor size, median (cm) | 12.3 (6–23) | 9.0 (0–23) | 0.001 |
Staging (ENSAT) [n (%)] | 0.04 | ||
1–2 | 18 (45) | 25 (68) | |
3–4 | 22 (55) | 12 (32) | |
Hormonal status [n (%)] | 0.76 | ||
Cushing | 6 (16) | 7 (19) | |
Non-Cushing | 31 (84) | 30 (81) | |
Weiss score, median | 6 (3–9) | 4 (3–9) | 0.02 |
Ki67 index (%) | 0.47 | ||
<10 | 25 (63) | 26 (70) | |
≥10 | 15 (37) | 11 (30) | |
Metastasis or local recurrence [n (%)]* | |||
Affected patients | 29 (72) | 15 (38) | 0.002 |
Non-affected patients | 11 (28) | 24 (62) |
ACC, adrenocortical carcinoma